Nanocurcumin prevents memory impairment, hippocampal apoptosis, Akt and CaMKII-α signaling disruption in the central STZ model of Alzheimer’s disease in rat

• Published in: Behavioural brain research 2024-08, Vol.471, p.115129, Article 115129
• Main Authors: Moosavi, Maryam, soukhaklari, Roksana, Bagheri-Mohammadi, Saeid, Firouzan, Bita, Javadpour, Pegah, Ghasemi, Rasoul
• Format: Article
• Language: English
• Subjects: Akt; Alzheimer Disease - drug therapy; Alzheimer Disease - metabolism; Alzheimer’s disease; Animals; Apoptosis - drug effects; Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism; CaMKII-α; Caspase 3 - metabolism; Curcumin - administration & dosage; Curcumin - pharmacology; Disease Models, Animal; Hippocampus; Hippocampus - drug effects; Hippocampus - metabolism; Male; Memory Disorders - drug therapy; Memory Disorders - prevention & control; Nanocurcumin; Neuroprotective Agents - administration & dosage; Neuroprotective Agents - pharmacology; Proto-Oncogene Proteins c-akt - metabolism; Rat; Rats; Rats, Wistar; Signal Transduction - drug effects; Streptozocin - pharmacology
• ISSN: 0166-4328; 1872-7549; 1872-7549
• DOI: 10.1016/j.bbr.2024.115129

The central route of streptozotocin (STZ) administration has been introduced as a rat model of sporadic Alzheimer’s disease (AD). Curcumin was suggested to possess possible neuroprotective effects, which may be profitable in AD. However, the low bioavailability of curcumin hinders its beneficial effects in clinical studies. Earlier studies suggested that a bovine serum albumin-based nanocurcumin, produces superior neuroprotective effects compared to natural curcumin. In the present study, the protective effect of nanocurcumin in rat model of central STZ induced memory impairment was assessed. In addition, due to the importance of the hippocampus in memory, the amounts of hippocampal active caspase-3, Akt, and CaMKII-α were evaluated. Adult male Wistar rats weighing 250–300 g were used. STZ (icv) was injected during days 1 and 3 (3 mg/kg in divided), and nanocurcumin or curcumin 50 mg/kg/oral gavage was administered daily during days 4–14. Morris water maze training was performed on days 15–17, and the retention memory test was achieved on the 18th day. Following memory assessment, the rats were sacrificed and the hippocampi were used to assess caspase-3 cleavage, Akt, and CaMKII-α signaling. The findings revealed that nanocurcumin ingestion (but not natural curcumin) in the dose of 50 mg/kg was capable to prevent the impairment of water maze learning and memory induced by central STZ. Molecular assessments indicated that STZ treatment increased the caspase-3 cleavage in the hippocampus while deactivating Akt and CaMKII-α. Nanocurcumin reduced caspase-3 cleavage to a non-significant level compared to control group and restored Akt and CaMKII-α within the hippocampus while natural curcumin exerted no significant effect. These findings might suggest that nanocurcumin can restore memory deficit, hippocampal apoptosis as well as Akt and CaMKII-α signaling disruption associated with brain insulin resistance. [Display omitted]